Premature discontinuation of clinical trial for reasons not related to efficacy, safety, or feasibility
BMJ
.
2001 Mar 10;322(7286):603-5.
doi: 10.1136/bmj.322.7286.603.
Authors
M Lièvre
1
,
J Ménard
,
E Bruckert
,
J Cogneau
,
F Delahaye
,
P Giral
,
E Leitersdorf
,
G Luc
,
L Masana
,
P Moulin
,
P Passa
,
D Pouchain
,
G Siest
Affiliation
1
Clinical Pharmacology Unit, Faculté de Médecine Laënnec, BP 8071, 69376 Lyons Cedex 08, France.
PMID:
11238162
PMCID:
PMC1119794
DOI:
10.1136/bmj.322.7286.603
No abstract available
Publication types
Review
MeSH terms
Clinical Trials Data Monitoring Committees
Clinical Trials as Topic / economics*
Committee Membership
Drug Industry*
Ethics, Medical
Humans
Research Design
Research Support as Topic*
Social Responsibility